Researchers reviewed and summarized the safety and efficacy of individual antispasmodics available in North America for the treatment of chronic abdominal pain.
Investigators assessed the safety and efficacy of tegaserod in women with IBS-C aged less than 65 years without a history of cardiovascular ischemic events.
Forty years after the emergence of HDV, the first anti-HDV therapeutic has been approved by the EMA, indicating the dawn of a new era for this difficult to treat disease
The American College of Gastroenterology released updated clinical guidelines on the prevention, diagnosis, and treatment of Clostridioides difficile infections.
Researchers compared the efficacy, adverse events, and compliance of HDDT vs BQT as first-line or rescue regimens and investigated factors contributing to H pylori eradication.
Researchers assessed the effects of different H pylori infections on distribution of histopathological characteristics and items of serum gastric function.
A team of investigators conducted a multicenter, randomized, controlled trial to identify factors related to the eradication of H pylori with dual vonoprazan and amoxicillin as first-line therapy.
A team of investigators explored the ability of different machine learning models to predict the risk of gastric cancer development in patients who had undergone eradication of Helicobacter pylori infection.
A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.
